Dr. Alter Discusses Research at JTCC

Video

Dr. Robert Alter on Current Research at John Theurer Cancer Center

Robert S. Alter, M.D. Co-chief, Urologic Oncology, John Theurer Cancer Center, discusses research taking place at the John Theurer Cancer Center, in the spring of 2011.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD
Related Content
Vikram M. Narayan, MD, Emory University Hospital; director, urological oncology, Grady Memorial Hospital; assistant professor, Department of Urology, Emory University School of Medicine; member, Winship Cancer Institute

Nadofaragene Firadenovec Sets the Stage for Gene Therapies in NMIBC

May 15th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
FDA

OncLive’s April Roundup of Key FDA Decisions in Oncology

May 14th 2024
Article
Terence Friedlander, MD

FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Urothelial Carcinoma

April 24th 2023
Podcast
Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center

Salvage Nivolumab/Ipilimumab Following Nivolumab Affords Treatment-Free Survival in RCC

May 11th 2024
Article
Renal Cell Carcinoma - stock.adobe.com

Retrospective Data Show Metastasectomy Plus Nephrectomy Improves Survival in Non–ccRCC

May 10th 2024
Article